Interferon Clearance Rate Decreased after Repeated Injections

References

1. Baron S., Buckler C. E., McCloskey R. V., Kirschstein R. L. 1966; The role of interferon during viremia,. I. Production of circulating interferon. Journal of Immunology 96:12
   [Google Scholar]
2. De Clercq E., Nuwer M. R., Merigan T. C. 1970; The role of interferon in the protective effect on a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. Journal of Clinical Investigation 49:1565
   [Google Scholar]
3. Gresser L., Fontaine D., Coppey J., Falcoff R., Falcoff E. 1967; Interferon and murine leukemia. II. Factors related to the inhibitory effect of interferon preparations on development of Friend leukemia in mice. Proceedings of the Society for Experimental Biology and Medicine 124:91
   [Google Scholar]
4. Hanna L., Merigan T. C., Jawetz E. 1966; Inhibition of TRIC agents by virus-induced interferon. Proceedings of the Society for Experimental Biology and Medicine 122:417
   [Google Scholar]
5. Ho M., Postic B. 1967; Prospects for applying interferon to man. In First International Conference on Vaccines against Viral and Rickettsial Diseases of Man p 632–649 Washington, D.C.: Pan American Health Organization;
   [Google Scholar]
6. Lowry O. H., Rosebrough H. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265
   [Google Scholar]
7. Merigan T. C., Finkelstein M. S. 1968; Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers. Virology 35:363
   [Google Scholar]
8. Subrahmanyan T. P., Mims C. A. 1966; Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. British Journal of Experimental Pathology 47:168
   [Google Scholar]